Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection

Karabay, Oğuz

DSpace Home
→
Fakülteler / Faculties
→
Tıp Fakültesi
→
Dahili Tıp Bilimleri / Internal Medıcal Scıences
→
Makale Koleksiyonu
→
View Item

dc.contributor.authors	Karabay, O; Tuna, N; Esen, S;
dc.date.accessioned	2020-02-27T08:34:23Z
dc.date.available	2020-02-27T08:34:23Z
dc.date.issued	2012
dc.identifier.citation	Karabay, O; Tuna, N; Esen, S; (2012). Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 24, 1301-1296
dc.identifier.issn	0954-691X
dc.identifier.uri	https://doi.org/10.1097/MEG.0b013e328356eac2
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66439
dc.description.abstract	Conclusion According to our results, for HBe antigen-negative CHB cases, the response rate during the sixth month after the treatment with PegIFN was determined to be similar to 17%. No difference was found between the efficacy rates of the two PegIFN products used in the treatment of HBe antigen-negative CHB. Eur J Gastroenterol Hepatol 24: 1296-1301 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
dc.language	English
dc.publisher	LIPPINCOTT WILLIAMS & WILKINS
dc.subject	Gastroenterology & Hepatology
dc.title	Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection
dc.type	Article
dc.identifier.volume	24
dc.identifier.startpage	1296
dc.identifier.endpage	1301
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Karabay, Oğuz
dc.relation.journal	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
dc.identifier.wos	WOS:000309553900009
dc.identifier.doi	10.1097/MEG.0b013e328356eac2
dc.identifier.eissn	1473-5687
dc.contributor.author	Karabay, Oğuz